Evidence map›Paper›PMID 42337062›Full record

ArticleNature biomedical engineering2026

Implementing trust in non-small cell lung cancer diagnosis with a conformalized uncertainty-aware AI framework.

Xiaoge Zhang, Tao Wang, Chao Yan, Fedaa Najdawi, Kai Zhou, Yuan Ma, Yiu-Ming Cheung, Maximus C F Yeung, Bradley A Malin

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Xiaoge Zhang *Department of Industrial and Systems Engineering, State Key Laboratory of Ultra-precision Machining Technology, and Research Institute for Artificial Intelligence of Things, The Hong Kong Polytechnic University, Hong Kong, China. xiaoge.zhang@polyu.edu.hk.ORCID http://orcid.org/0000-0001-6831-3175
Tao Wang *Department of Industrial and Systems Engineering, State Key Laboratory of Ultra-precision Machining Technology, and Research Institute for Artificial Intelligence of Things, The Hong Kong Polytechnic University, Hong Kong, China.ORCID http://orcid.org/0000-0003-0201-8100
Chao Yan *Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-6719-1388
Fedaa NajdawiDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Kai ZhouDepartment of Computing, The Hong Kong Polytechnic University, Hong Kong, China.
Yuan MaDepartment of Mechanical Engineering and Research Institute for Intelligent Wearable Systems, The Hong Kong Polytechnic University, Hong Kong, China.ORCID http://orcid.org/0000-0002-4794-5496
Yiu-Ming CheungDepartment of Computer Science, Hong Kong Baptist University, Hong Kong, China.
Maximus C F YeungDepartment of Pathology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China. mcfyeung@hku.hk.ORCID http://orcid.org/0000-0001-9942-0109
Bradley A MalinDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA. b.malin@vumc.org.

Funding

Generative AI for synthetic data: A framework to expand health data reach for research and ensure algorithmic fairnessK99LM014428 · NLM · VANDERBILT UNIVERSITY MEDICAL CENTER · PI YAN, CHAO · 2024 to 2025
$174k
National Natural Science Foundation of China (National Science Foundation of China) 62406269NLM NIH HHS K99 LM014428Research Grants Council, University Grants Committee (RGC, UGC) 25206422U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine (NLM) 1K99LM014428-01A1
6 · The paper itself

Abstract

Ensuring trustworthiness is fundamental in cancer diagnostics, where a misdiagnosis can have dire consequences. Current pathology AI models lack systematic solutions to address trustworthiness concerns arising from model limitations and data discrepancies between model deployment and development environments. Here we introduce TRUECAM (Trustworthiness-focused, Uncertainty-aware, End-to-end Cancer diagnosis with Model-agnostic capabilities), a framework designed to ensure both data and model trustworthiness for non-small cell lung cancer subtyping with whole-slide images. TRUECAM integrates (1) a spectral-normalized neural Gaussian process for identifying out-of-scope inputs, (2) an ambiguity-guided tile elimination to filter out highly ambiguous regions, addressing data trustworthiness, and (3) conformal prediction to ensure controlled error rates. We systematically evaluated TRUECAM across multiple cancer datasets using both task-specific and foundation models. Computational experiments suggest that models wrapped with TRUECAM consistently outperformed their unwrapped counterparts in classification accuracy, robustness, interpretability, data efficiency and fairness. These findings establish TRUECAM as a versatile framework for the responsible deployment of pathology AI in real-world settings.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.